Feasibility of spray drying bacteriophages into respirable powders to combat pulmonary bacterial infections

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 84, Issue 3, 2013, Pages 578-582

  Vandenheuvel, Dieter ^a   Singh, Abhishek ^a   Vandersteegen, Katrien ^a   Klumpp, Jochen ^b   Lavigne, Rob ^a   Van Den Mooter, Guy ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Institute of Food   (Switzerland)

Author keywords

Bacteriophage; Bacteriophage therapy; Formulation; Pulmonary drug delivery; Spray drying

Indexed keywords

LACTOSE; TREHALOSE;

AIR TEMPERATURE; ARTICLE; BACTERIAL INFECTION; BACTERIOPHAGE; DRUG DELIVERY SYSTEM; DRY POWDER; FEASIBILITY STUDY; LUNG INFECTION; NEBULIZATION; NONHUMAN; PARTICLE SIZE; PSEUDOMONAS PODOVIRUS; SHEAR STRESS; SPRAY DRYING; TEMPERATURE STRESS; VIRUS SURVIVAL;

ADMINISTRATION, INHALATION; BACTERIAL INFECTIONS; BACTERIOPHAGES; CHEMISTRY, PHARMACEUTICAL; DESICCATION; DEXTRANS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRY POWDER INHALERS; EXCIPIENTS; FEASIBILITY STUDIES; HUMANS; LACTOSE; LUNG DISEASES; PARTICLE SIZE; POWDERS; PSEUDOMONAS; STAPHYLOCOCCUS; TEMPERATURE; TREHALOSE;

EID: 84879121471     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.12.022     Document Type: Article

References (44)

1. K. Vandersteegen, W. Mattheus, P.-J. Ceyssens, F. Bilocq, D. De Vos, J.-P. Pirnay, J.-P. Noben, M. Merabishvili, U. Lipinska, K. Hermans, and R. Lavigne Microbiological and molecular assessment of bacteriophage ISP for the control of Staphylococcus aureus Plos One 6 2011 e24418
2. J.J. Gill, and P. Hyman Phage choice, isolation, and preparation for phage therapy Curr. Pharm. Biotechnol. 11 2010 2 14
3. J.-P. Pirnay, D. De Vos, G. Verbeken, M. Merabishvili, N. Chanishvili, M. Vaneechoutte, M. Zizi, G. Laire, R. Lavigne, I. Huys, G. Van den Mooter, A. Buckling, L. Debarbieux, F. Pouillot, J. Azeredo, E. Kutter, A. Dublanchet, A. Górski, and R. Adamia The phage therapy paradigm: Prêt-à- porter or sur-mesure Pharm. Res. 28 2011 934 937
4. A. Sulakvelidze, Z. Alavidze, and J.G. Morris Jr. Bacteriophage therapy Antimicrob. Agents Chemother. 45 2001 649 659
5. M. Kutateladze, and R. Adamia Bacteriophages as potential new therapeutics to replace or supplement antibiotics Trends Biotechnol. 28 2010 591 595
6. G. Verbeken, J.-P. Pirnay, D. De Vos, S. Jennes, M. Zizi, R. Lavigne, M. Casteels, and I. Huys Optimizing the European regulatory framework for sustainable bacteriophage therapy in human medicine Arch. Immunol. Ther. Exp. 60 2012 161 172
7. G.B. Winnie, and R.G. Cowan Respiratory tract colonization with Pseudomonas aeruginosa in cystic fibrosis: correlations between anti-Pseudomonas aeruginosa antibody levels and pulmonary function Pedriatr. Pulmonol. 10 1991 92 100
8. J.B. Lyczak, C.L. Cannon, and G.B. Pier Lung infections associated with cystic fibrosis Clin. Micriobiol. Rev. 15 2002 194 222
9. F. Harrison Microbial ecology of the cystic fibrosis lung Microbiology 153 2007 917 923
10. K.W. Southern, P.M. Barker, A. Solis-Moya, and L. Patel Macrolide antibiotics for cystic fibrosis Cochrane Database Syst. Rev. 2011
11. P.B. Davis Cystic fibrosis since 1938 Am. J. Respir. Crit. Care Med. 173 2006 1938 475 482
12. M.L. Hutchison, and J.R.W. Govan Pathogenicity of microbes associated with cystic fibrosis Microbes Infect. 1 1999 1005 1014
13. L. Debarbieux, D. Leduc, D. Maura, E. Morello, A. Criscuolo, O. Grossi, V. Balloy, and L. Touqui Bacteriophages can treat and prevent Pseudomonas aeruginosa lung infections J. Infect. Dis. 201 2010 1096 1104
14. D. Alemayehu, P.G. Casey, O. McAuliffe, C.M. Guinane, J.G. Martin, F. Shanahan, A. Coffey, R.P. Ross, and C. Hill Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells MBio 3 2012 e00029 12
15. L. Golshahi, K.D. Seed, J.J. Dennis, and W.H. Finlay Toward modern inhalational bacteriophage therapy: Nebulization of bacteriophages of Burkholderia cepacia complex J. Aerosol Med. Pulm. Drug Deliv. 21 2008 351 359
16. R.J. Malcolmson, and J.K. Embleton Dry powder formulations for pulmonary delivery Pharm. Sci. Technol. Today 1 1998 394 398
17. C. Bosquillon, C. Lombry, V. Préat, and R. Vanbever Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance J. Control. Release 70 2001 329 339
18. H. Cabral-Marques, and R. Almeida Optimisation of spray-drying process variables for dry powder inhalation (DPI) formulations of corticosteroid/ cyclodextrin inclusion complexes Eur. J. Pharm. Biopharm. 73 2009 121 129
19. M. Ameri, and Y.-F. Maa Spray drying of biopharmaceuticals: stability and process considerations Dry Technol. 24 2006 763 768
20. S.A. Shoyele, and S. Cawthorne Particle engineering techniques for inhaled biopharmaceuticals Adv. Drug Deliv. Rev. 58 2006 1009 1029
21. M.J. Maltesen, S. Bjerregaard, L. Hovgaard, S. Havelund, and M. van de Weert Quality by design - spray drying of insulin intended for inhalation Eur. J. Pharm. Biopharm. 70 2008 828 838
22. S. Matinkhoo, K.H. Lynch, J.J. Dennis, W.H. Finlay, and R. Vehring Spray-dried respirable powders containing bacteriophages for the treatment of pulmonary infections J. Pharm. Sci. 100 2011 5197 5205
23. I. Folková, L.X. Huang, and A.S. Mujumdar Industrial spray drying systems A.S. Mujumdar, Handbook of Industrial Drying 2006 CRC Press Florida 215 256
24. P.-J. Ceyssens, J.-P. Noben, H.-W. Ackermann, J. Verhaegen, D. De Vos, J.-P. Pirnay, M. Merabishvili, M. Vaneechoutte, A. Chibeu, G. Volckaert, and R. Lavigne Survey of Pseudomonas aeruginosa and its phages: de novo peptide sequencing as a novel tool to assess the diversity of worldwide collected viruses Environ. Microbiol. 11 2009 1303 1313
25. M.D. Adams Bacteriophages 1959 Interscience Publishers New York
26. R. Vehring Pharmaceutical particle engineering via spray drying Pharm. Res. 25 2008 999 1022
27. L.M. Crowe, D.S. Reid, and J.H. Crowe Is trehalose special for preserving dry biomaterials? Biophys. J. 71 1996 2087 2093
28. R.T. Forbes, K.G. Davis, M. Hindle, J.G. Clarke, and J. Maas Water vapor sorption studies on the physical stability of a series of spray-dried protein/sugar powders for inhalation J. Pharm. Sci. 87 1998 1316 1321
29. J.D. Andya, Y.-F. Maa, H.R. Costantino, P.-A. Nguyen, N. Dasovich, T.D. Sweeney, C.C. Hsu, and S.J. Shire The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody Pharm. Res. 16 1999 350 358
30. Y.-H. Liao, M.B. Brown, T. Nazir, A. Quader, and G.P. Martin Effects of sucrose and trehalose on the preservation of the native structure of spray-dried lysozyme Pharm. Res. 19 2002 1847 1853
31. N. Sadrzadeh, D.P. Miller, D. Lechuga-Ballesteros, N.J. Harper, C.L. Stevenson, and D.B. Bennett Solid-state stability of spray-dried insulin powder for inhalation: chemical kinetics and structural relaxation modeling of Exubera above and below the glass transition temperature J. Pharm. Sci. 99 2010 3698 3710
32. S. Barghouthi, L.M. Guerdoud, and D.P. Speert Inhibition by dextran of Pseudomonas aeruginosa adherence to epithelial cells Am. J. Respir. Crit. Care Med. 154 1996 1788 1793
33. W. Feng, H. Garrett, D.P. Speert, and M. King Improved clearability of cystic fibrosis sputum with dextran treatment in vitro Am. J. Respir. Crit. Care Med. 157 1998 710 714
34. A.H.L. Chow, H.H.Y. Tong, P. Chattopadhyay, and B.Y. Shekunov Particle engineering for pulmonary drug delivery Pharm. Res. 24 2007 411 437
35. M. Odziomek, T.R. Sosnowski, and L. Gradoń Conception, preparation and properties of functional carrier particles for pulmonary drug delivery Int. J. Pharm. 433 2012 51 59
36. N.K. Jain, and I. Roy Effect of trehalose on protein structure Protein Sci. 18 2009 24 36
37. Y. You, M. Zhao, G. Liu, and X. Tang Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method J. Pharm. Pharmacol. 59 2007 927 934
38. Y.H. Roos Importance of glass transition and water activity to spray drying and stability of dairy powders Lait 82 2002 475 484
39. M. Adler, and G. Lee Stability and surface activity of lactate dehydrogenase in spray-dried trehalose J. Pharm. Sci. 88 1999 199 208
40. A. Millqvist-Fureby, M. Malmsten, and B. Bergenståhl An aqueous polymer two-phase system as carrier in the spray-drying of biological material J. Colloid Interface Sci. 225 2000 54 61
41. P.R.M. Steele Morphological manifestations of freezing and thawing injury in bacteriophage T4Bo J. Hyg. 77 1976 119 127
42. F. Arisaka, J. Engel, and H. Klump Contraction and dissociation of the bacteriophage T4 tail sheath induced by heat and urea Prog. Clin. Biol. Res. 64 1981 365 379
43. R. Vanbever, J.D. Mintzes, J. Wang, J. Nice, D. Chen, R. Batycky, R. Langer, and D.A. Edwards Formulation and physical characterization of large porous particles for inhalation Pharm. Res. 16 1999 1735 1742
44. K. Vandersteegen, A.M. Kropinski, J.H.E. Nash, J.P. Noben, K. Hermans R. Lavigne, Romulus and Remus, two phage isolates representing a distinct clade within the Twortlikevirus, display suitable properties for phage therapy applications. J. Virol. (2012), http://dx.doi.org/10.1128/JVl.02763-12.